PTLD patients had decreased frequencies of CXCR5+ CD4 naïve T cells, an increased prevalence of CD8 Th1-like cells (with a corresponding decrease in Th1/17-like cells), and an increased prevalence of CD57+ HLA-DR+ CD4 EMRA cells. This evidence concerns the gene CD8A and post-transplant lymphoproliferative disease.